US biotech firm completes 95% of dodo genome, targets bird’s possible revival
Global - Asia
Archived
•
October 15, 2026
•
Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction.
Source: Times of India | https://timesofindia.indiatimes.com/rssfeedstopstories.cms - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



